Revvity Schedules Q1 2026 Earnings Call Amid Growth Trajectory
Event summary
- Revvity will release Q1 2026 financial results on May 5, 2026, ahead of market open.
- CEO Prahlad Singh and CFO Max Krakowiak will host the earnings call at 7:30 a.m. ET.
- Revvity reported $2.9 billion in revenue for 2025 with 11,000 employees globally.
- The company operates in health science solutions, including multi-omics, diagnostics, and informatics.
The big picture
Revvity's earnings call comes at a critical juncture as the company seeks to capitalize on its $2.9 billion revenue base and expand its footprint in health science solutions. The call will provide insights into how Revvity is navigating industry trends, such as the increasing demand for multi-omics technologies and advanced diagnostics, while maintaining its position as a key player in the S&P 500.
What we're watching
- Revenue Growth
- How Revvity's Q1 2026 results will reflect its 2025 performance and strategic investments in health science solutions.
- Market Positioning
- Whether Revvity can sustain its growth trajectory amid increasing competition in the diagnostics and biotech sectors.
- Operational Efficiency
- The pace at which Revvity integrates its diverse health science solutions to drive operational efficiency and innovation.
Related topics